Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
Capability Reset all filters
01 1Early Clinical / Phase I-IIa
Country Reset all filters
01 1U.S.A
PHASE I & II CLINICAL STUDY
Pharma Service : Clinical Trials
AVM Biotechnology
AVM Biotechnology is actively enrolling patients in an open-label adaptive design expansion cohort pivotal phase 1/2 study in relapsed/refractory non-hodgkin’s lymphoma and leukemia at major cancer treatment centers in the US.
Category : Early Clinical / Phase I-IIa
Sub Category : Phase I / IIa
ServiceWeb Link
Capabilities#ServicesBio
MarketPlace